Welcome to the CJU website » LOG IN


Low-risk prostate cancer patient: active treatment
Division of Urological Surgery, Duke University Medical Center, Durham, NC, USA
Jun 2005 (Vol. 12, Issue 31, Pages( 25 - 27)


Text-Size + 

  • We currently lack a prospective, randomized, multicenter trial, to reassure low-risk prostate cancer patients, especially younger ones, that watchful waiting is a legitimate treatment. To better manage these patients, we need to: first, confirm that the patient has low-risk prostate cancer; second, adapt the treatment to the risk (i.e., if therapy is chosen over watchful waiting, it should be monotherapy not multiple therapy); third, be aware of age migration; fourth, know that radical prostatectomy and radiation were shown to be very effective for these patients at 10-year follow-up; and lastly, make an effort to better define watchful waiting and embrace it more, to avoid overtreatment.

Current Issue

February 2019, Vol.26 No.1
canadian journal of urology mobile

canadian journal of urology